Showing 801-810 of 1718 results for "".
- When and How to Discontinue AED Therapy in People with Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1007Epilepsy-pdf/31115/Discontinuation of Antiepileptic Drugs: Balancing Benefits and RisksAntiepileptic drugs (AEDs) have been the cornerstone of seizure disorder management for over seven decades, evolving from phenobarbital to more than two dozen agents. A critical question arises when patients achieve seizure freedom:
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0807-pain-mngmnt-pdf/31138/In the inaugural part of a two-part series, Dr. Charles Argoff explores the intricate relationship between neuropathic pain, sleep disturbances, and psychiatric disorders such as depression and anxiety. Neuropathic pain, arising from lesions or dysfunctions within the peripheral or central nervous s
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0407-dementia-pdf/31186/As spring and summer travel seasons approach, attention often focuses on fuel prices and their impact on travel patterns. Analogously, the brain operates under a supply-and-demand framework for energy, where glucose and oxygen serve as essential “fuels.” When the brain’s energy demand surpasses supp
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31140/Impact of SSRIs on Bone Health in Elderly Patients: Clinical InsightsRecent studies have raised concerns about the use of selective serotonin reuptake inhibitors (SSRIs) and their potential negative effects on bone health in older adults. These findings pose important considerations for neurologists
- Should Migraine Patients Undergo PFO Closure?https://practicalneurology.com/diseases-diagnoses/headache-pain/pn1206pfo-fea-pdf/31242/The relationship between patent foramen ovale (PFO) and migraine, particularly migraine with aura (MA), has garnered significant attention in neurology. PFO, a remnant of fetal circulation, persists in approximately 25% of adults, while migraines affect about 11% of the population. The concurrent pr
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31434/The resurgence of the antiplatelet resistance debate has rekindled discussions within the stroke care community, particularly concerning the optimal aspirin dosage for stroke prophylaxis. Historically, low-dose aspirin (≤325 mg) has been deemed as effective as higher doses in preventing both cardiov
Medical Marijuana: Composition, Neurological Benefits, And Adverse Events
https://practicalneurology.com/diseases-diagnoses/headache-pain/medical-marijuana-composition-neurological-benefits-and-adverse-events/30512/Exploring the potential benefits of medical marijuana in neurology and future directions in care.Ruling Out Secondary Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/ruling-out-secondary-headache/30260/A careful history and high degree of suspician are needed for accurate diagnosis.Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.